BioNotebook: Seattle Genetics/AbbVie, Auspex, Flexion, Ironwood
This article was originally published in Scrip
Executive Summary
AbbVie extends Seattle Genetics collaboration; Auspex raises $35m; Flexion files for $86m IPO; and Ironwood makes 10% jobs cut.